Podcast

Share

Program Content

Activities

  • CDK4 6 Inhibitors for Breast Cancer
    Expert Insights and FAQs on CDK4/6 Inhibitors in the Care of Today’s Patients With HR-Positive/HER2-Negative Breast Cancer
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 20, 2025

    Expires: August 19, 2025

Provided by

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation